Last reviewed · How we verify

NCT07177534

Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model

Not yet recruiting Last updated 17 September 2025
What this trial tests

trial testing No intervention in Uterine Fibroids in 7,084 participants. Not yet recruiting.

Timeline
30 September 2025
Primary endpoint
30 September 2031
30 September 2031

Quick facts

Lead sponsorTongji Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment7,084
Start date30 September 2025
Primary completion30 September 2031
Estimated completion30 September 2031

Drugs / interventions tested

Conditions studied

Sponsor

Tongji Hospital

Who can join

Adults 20 to 50, female only, with Uterine Fibroids or Female Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Female fertility may be affected by uterine fibroids, although this association has not been elucidated. Our retrospective study has already constructed a predictive model for infertility risk in patients with uterine fibroids using machine learning. We will now validate and optimize this model through a prospective study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Uterine Fibroids

Currently open trials in the same condition.

Other Tongji Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07177534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing